APA (7th ed.) Citation

Tao, Y., Li, T., Lin, P., Jiang, X., Shi, P., Fu, Y., . . . Cao, Y. (2023). A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers. Clinical Pharmacology in Drug Development, 12(1), 65. https://doi.org/10.1002/cpdd.1182

Chicago Style (17th ed.) Citation

Tao, Ye, et al. "A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers." Clinical Pharmacology in Drug Development 12, no. 1 (2023): 65. https://doi.org/10.1002/cpdd.1182.

MLA (9th ed.) Citation

Tao, Ye, et al. "A Randomized, Open‐Label, Phase I Clinical Study of Dalpiciclib With Different Specifications After Process Modification in Healthy Chinese Volunteers." Clinical Pharmacology in Drug Development, vol. 12, no. 1, 2023, p. 65, https://doi.org/10.1002/cpdd.1182.